CA2107329A1 - Anti-Human Immunodeficiency Virus Recombinant Antibodies - Google Patents
Anti-Human Immunodeficiency Virus Recombinant AntibodiesInfo
- Publication number
- CA2107329A1 CA2107329A1 CA2107329A CA2107329A CA2107329A1 CA 2107329 A1 CA2107329 A1 CA 2107329A1 CA 2107329 A CA2107329 A CA 2107329A CA 2107329 A CA2107329 A CA 2107329A CA 2107329 A1 CA2107329 A1 CA 2107329A1
- Authority
- CA
- Canada
- Prior art keywords
- immunodeficiency virus
- human immunodeficiency
- recombinant antibodies
- virus recombinant
- combining site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940098197 human immunoglobulin g Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
This invention provides hybrid antibodies which comprise a base portion which corresponds to the constant portion of human immunoglobulin G, a combining site selected for specificity to the particular target antigen, and a combining site which binds to and activates human CTL.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68737691A | 1991-04-18 | 1991-04-18 | |
US07/687,376 | 1991-04-18 | ||
PCT/US1992/002975 WO1992018540A1 (en) | 1991-04-18 | 1992-04-10 | Anti-human immunodeficiency virus recombinant antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2107329A1 true CA2107329A1 (en) | 1992-10-19 |
CA2107329C CA2107329C (en) | 1999-04-27 |
Family
ID=24760226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002107329A Expired - Fee Related CA2107329C (en) | 1991-04-18 | 1992-04-10 | Anti-human immunodeficiency virus recombinant antibodies |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0580758A4 (en) |
JP (1) | JPH06506947A (en) |
AU (1) | AU672580B2 (en) |
CA (1) | CA2107329C (en) |
IL (1) | IL101602A (en) |
WO (1) | WO1992018540A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2047244C (en) * | 1989-02-24 | 2002-09-17 | Zanetti Maurizio | Genetically engineered immunoglobulins |
US5969109A (en) * | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
GB0102145D0 (en) * | 2001-01-26 | 2001-03-14 | Scancell Ltd | Substances |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338518C (en) * | 1987-09-23 | 1996-08-13 | Joyce M. Zarling | Antibody heteroconjugates for the killing of hiv-infected cells |
ES2131107T3 (en) * | 1992-03-17 | 1999-07-16 | Novartis Ag | ANTIBODIES OBTAINED THROUGH GENETIC ENGINEERING. |
DE69311764T2 (en) * | 1992-05-14 | 1998-02-05 | Polymun Scient Immunbio Forsch | Peptides that induce antibodies that neutralize genetically divergent HIV-1 isolations |
-
1992
- 1992-04-10 JP JP4510879A patent/JPH06506947A/en active Pending
- 1992-04-10 CA CA002107329A patent/CA2107329C/en not_active Expired - Fee Related
- 1992-04-10 AU AU18919/92A patent/AU672580B2/en not_active Ceased
- 1992-04-10 EP EP92911196A patent/EP0580758A4/en not_active Withdrawn
- 1992-04-10 WO PCT/US1992/002975 patent/WO1992018540A1/en not_active Application Discontinuation
- 1992-04-16 IL IL10160292A patent/IL101602A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU672580B2 (en) | 1996-10-10 |
EP0580758A1 (en) | 1994-02-02 |
CA2107329C (en) | 1999-04-27 |
AU1891992A (en) | 1992-11-17 |
IL101602A (en) | 1996-10-31 |
WO1992018540A1 (en) | 1992-10-29 |
JPH06506947A (en) | 1994-08-04 |
IL101602A0 (en) | 1992-12-30 |
EP0580758A4 (en) | 1995-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2149120A1 (en) | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof | |
IL83113A (en) | Bifunctional antibodies having antigen specificity for fc receptor and for an epitope of a target cell | |
WO1994029451A3 (en) | Humanised antibodies | |
CA2025597A1 (en) | Vaccine against lyme disease | |
CA2118010A1 (en) | Antibodies specific for carcinoma-associated antigens | |
TNSN93012A1 (en) | DESIGN, CLONING AND EXPRESSION OF HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-5 | |
WO1994004691A3 (en) | Dimer and multimer forms of single chain polypeptides | |
AU4230493A (en) | Diphtheria toxin receptor-binding region | |
EP1266965A3 (en) | Recombinant antibodies for human therapy | |
WO1999003987A3 (en) | Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy | |
CA2109815A1 (en) | Antibody preparation | |
HK1115607A1 (en) | Human cytokine receptor | |
AU676859B2 (en) | Synthetic peptides, antibodies against them and their use | |
AU628948B2 (en) | Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof | |
EP1350799A3 (en) | Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor | |
CA2091263A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
DE3650032D1 (en) | ANTICYTOMEGALOVIRAL HUMAN MONOCLONAL ANTIBODIES AND THEIR PRODUCTION. | |
AU7203194A (en) | Bispecific human monoclonal antibodies specific for human immunodeficiency virus | |
AU1125192A (en) | Fusion proteins for prodrug activation, the preparation and use thereof | |
CA2107329A1 (en) | Anti-Human Immunodeficiency Virus Recombinant Antibodies | |
AU2032988A (en) | A genus-specific listeria antigen identified by monoclonal antibodies | |
ATE211148T1 (en) | HCMV-SPECIFIC PEPTIDES AND THEIR USE | |
AU1423892A (en) | Monoclonal antibodies directed towards mycobacterial antigens | |
CA2070182A1 (en) | Chimeric immunoglobulin for cd4 receptors | |
AU4959193A (en) | High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |